2,101 results on '"Gazdar, A F"'
Search Results
2. A biobank of small cell lung cancer CDX models elucidates inter- and intratumoral phenotypic heterogeneity
3. Lung Cancer
4. Inosine Monophosphate Dehydrogenase Dependence in a Subset of Small Cell Lung Cancers
5. Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data
6. Inhibition of Lung Cancer Cell Growth and Induction of Apoptosis after Reexpression of 3p21.3 Candidate Tumor Suppressor Gene SEMA3B
7. Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development.
8. Data from Crebbp Loss Drives Small Cell Lung Cancer and Increases Sensitivity to HDAC Inhibition
9. Supplementary Figures 1-4 from Knockdown of Oncogenic KRAS in Non–Small Cell Lung Cancers Suppresses Tumor Growth and Sensitizes Tumor Cells to Targeted Therapy
10. Data from Knockdown of Oncogenic KRAS in Non–Small Cell Lung Cancers Suppresses Tumor Growth and Sensitizes Tumor Cells to Targeted Therapy
11. Supplementary Tables 1-2 from Knockdown of Oncogenic KRAS in Non–Small Cell Lung Cancers Suppresses Tumor Growth and Sensitizes Tumor Cells to Targeted Therapy
12. Figures S1-S16 from Crebbp Loss Drives Small Cell Lung Cancer and Increases Sensitivity to HDAC Inhibition
13. Supplementary Table 3 from Knockdown of Oncogenic KRAS in Non–Small Cell Lung Cancers Suppresses Tumor Growth and Sensitizes Tumor Cells to Targeted Therapy
14. Data from Human Lung Epithelial Cells Progressed to Malignancy through Specific Oncogenic Manipulations
15. Supplementary Methods, Tables 1 - 4, Figures 1 - 7 from Human Lung Epithelial Cells Progressed to Malignancy through Specific Oncogenic Manipulations
16. Tables S1-S5 from Crebbp Loss Drives Small Cell Lung Cancer and Increases Sensitivity to HDAC Inhibition
17. Supplementary Methods from Knockdown of Oncogenic KRAS in Non–Small Cell Lung Cancers Suppresses Tumor Growth and Sensitizes Tumor Cells to Targeted Therapy
18. Supplementary Figure Legends 1-4 from Knockdown of Oncogenic KRAS in Non–Small Cell Lung Cancers Suppresses Tumor Growth and Sensitizes Tumor Cells to Targeted Therapy
19. Supplementary Table 1 from An Expression Signature as an Aid to the Histologic Classification of Non–Small Cell Lung Cancer
20. Supplementary Figures and Tables from GLI1 Blockade Potentiates the Antitumor Activity of PI3K Antagonists in Lung Squamous Cell Carcinoma
21. Supplementary Material from An Expression Signature as an Aid to the Histologic Classification of Non–Small Cell Lung Cancer
22. Data from GLI1 Blockade Potentiates the Antitumor Activity of PI3K Antagonists in Lung Squamous Cell Carcinoma
23. Data from Abnormalities of the TITF-1 Lineage-Specific Oncogene in NSCLC: Implications in Lung Cancer Pathogenesis and Prognosis
24. Supplementary Methods, Figures 1 - 7, and Tables 1 - 6 from Radiation-Enhanced Lung Cancer Progression in a Transgenic Mouse Model of Lung Cancer Is Predictive of Outcomes in Human Lung and Breast Cancer
25. Supplementary Figures from An Expression Signature as an Aid to the Histologic Classification of Non–Small Cell Lung Cancer
26. Supplementary Table 2 from An Expression Signature as an Aid to the Histologic Classification of Non–Small Cell Lung Cancer
27. Supplementary Data from Color Fluorescence Ratio for Detection of Bronchial Dysplasia and Carcinoma In situ
28. Supplementary Data from Abnormalities of the TITF-1 Lineage-Specific Oncogene in NSCLC: Implications in Lung Cancer Pathogenesis and Prognosis
29. Supplementary Figure 4 from Acquired Resistance to EGFR Inhibitors Is Associated with a Manifestation of Stem Cell–like Properties in Cancer Cells
30. Data Supplement from A Search for Novel Cancer/Testis Antigens in Lung Cancer Identifies VCX/Y Genes, Expanding the Repertoire of Potential Immunotherapeutic Targets
31. Data from PIK3CA Mutations and Copy Number Gains in Human Lung Cancers
32. Supplementary Table S2 from Molecular Portraits of Epithelial, Mesenchymal, and Hybrid States in Lung Adenocarcinoma and Their Relevance to Survival
33. Data from A Search for Novel Cancer/Testis Antigens in Lung Cancer Identifies VCX/Y Genes, Expanding the Repertoire of Potential Immunotherapeutic Targets
34. Supplementary Table 4 from YEATS4 Is a Novel Oncogene Amplified in Non–Small Cell Lung Cancer That Regulates the p53 Pathway
35. Supplementary Table 2 from Acquired Resistance to EGFR Inhibitors Is Associated with a Manifestation of Stem Cell–like Properties in Cancer Cells
36. Supplementary Figure 2 from Acquired Resistance to EGFR Inhibitors Is Associated with a Manifestation of Stem Cell–like Properties in Cancer Cells
37. Supplementary Figure 1 from Non–Small Cell Lung Cancers with Kinase Domain Mutations in the Epidermal Growth Factor Receptor Are Sensitive to Ionizing Radiation
38. Supplementary Figure 1 from PIK3CA Mutations and Copy Number Gains in Human Lung Cancers
39. Supplementary Figure 5 from Oxygen Concentration Determines the Biological Effects of NOTCH-1 Signaling in Adenocarcinoma of the Lung
40. Data from Cytoglobin, the Newest Member of the Globin Family, Functions as a Tumor Suppressor Gene
41. Supplementary Figure 9 from Immortalization of Human Bronchial Epithelial Cells in the Absence of Viral Oncoproteins
42. Data from Epidermal Growth Factor Receptors with Tyrosine Kinase Domain Mutations Exhibit Reduced Cbl Association, Poor Ubiquitylation, and Down-regulation but Are Efficiently Internalized
43. Supplementary Table and Figure Legends from Molecular Portraits of Epithelial, Mesenchymal, and Hybrid States in Lung Adenocarcinoma and Their Relevance to Survival
44. Supplementary Figure 3 from Acquired Resistance to EGFR Inhibitors Is Associated with a Manifestation of Stem Cell–like Properties in Cancer Cells
45. Data from SMAC Mimetic (JP1201) Sensitizes Non–Small Cell Lung Cancers to Multiple Chemotherapy Agents in an IAP-Dependent but TNF-α–Independent Manner
46. Supplementary Figure S2 from Molecular Portraits of Epithelial, Mesenchymal, and Hybrid States in Lung Adenocarcinoma and Their Relevance to Survival
47. Supplementary Figure 1 from Cytoglobin, the Newest Member of the Globin Family, Functions as a Tumor Suppressor Gene
48. Supplementary Figures 1-8 from Immortalization of Human Bronchial Epithelial Cells in the Absence of Viral Oncoproteins
49. Supplementary Figure 1 from Dual Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Blockade Is an Effective Radiosensitizing Strategy for the Treatment of Non–Small Cell Lung Cancer Harboring K-RAS Mutations
50. Data from Steroid Receptor Coactivator-3 Expression in Lung Cancer and Its Role in the Regulation of Cancer Cell Survival and Proliferation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.